Subcutaneous immunoglobulin (SCIg) therapy
Unlike intravenous administration, which infuses medication into a vein, subcutaneous therapy uses a small needle that is inserted into the tissue just below the surface of the skin in one or more areas of the body (such as the stomach, thigh, upper arm, or hip). A small, portable pump controls the amount and rate of the infusion. With physician’s approval, patients or caregivers are able to administer therapy themselves, so there is no need to travel to a hospital, infusion center, or physician’s office for treatment, or to arrange to have a nurse present to administer therapy.
Subcutaneous infusions may be appropriate for patients who have small or collapsed veins (called poor venous access). Patients who have difficulty tolerating intravenous infusions or who have active lifestyles may also be candidates for subcutaneous immunoglobulin. Because SCIg is administered weekly, it produces steady Ig levels in the blood.
For more information on CSL Behring's subcutaneous immunoglobulin products, please click on the links below.
Hizentra
®Immune Globulin Subcutaneous (Human)